There is increasing interest in drug therapy for preventing aneurysmal subarachnoid
hemorrhage (aSAH). We aimed to comprehensively evaluate the association between drug …

Intracranial aneurysms (IA) are a disease process with potentially devastating outcomes,
particularly when rupture occurs leading to subarachnoid hemorrhage. While some …

Background: Mounting experimental evidence supports the concept that the RAAS (renin-
angiotensin-aldosterone system) is involved in the pathogenesis of intracranial aneurysm …

Background Intracranial aneurysmal subarachnoid hemorrhage (aSAH) is a dangerous and
highly fatal condition if ruptured. Significant advances have been made in the treatment of …

Subarachnoid hemorrhage being the rupture of intracranial aneurysm (IA) as a major cause
has quite poor prognosis, despite the modern technical advances. Thereby, the mechanisms …

Management of intracranial aneurysms (IAs) is determined by patient age, risk of rupture,
and comorbid conditions. While endovascular and microsurgical interventions offer solutions …

Introduction: Observational studies suggest that different classes of antihypertensive drugs
may have different effects on the occurrence of intracranial aneurysms (IA) and …

Background and Objectives Current benefits of invasive intracranial aneurysm treatment to
prevent aneurysmal subarachnoid hemorrhage (aSAH) rarely outweigh treatment risks. Most …

Objectives Studies assessing aneurysm rupture “risk” based on comparative retrospective
analyses of medications taken on presentation may be subject to presentation bias. Are …

Intracranial aneurysms (IAs) are dilated lesions of the arterial wall caused by a dysfunction
of the hemodynamic stress, leading to subarachnoid hemorrhage, which can be devastating …